Որոնման արդյունքները - Per Guldberg
- Ցուցադրվում են 1 - 20 արդյունքները 30
- Գնացեք Հաջորդ էջ
-
1
The genome and epigenome of malignant melanoma Christina Dahl, Per Guldberg
Հրապարակվել է 2007Revisão -
2
-
3
-
4
DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies Louise Katrine Larsen, Guro E. Lind, Per Guldberg, Christina Dahl
Հրապարակվել է 2019Revisão -
5
-
6
-
7
-
8
-
9
-
10
-
11
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment Michael Daskalakis, TuDung T. Nguyen, Carvell T. Nguyen, Per Guldberg, Gabriele Köhler, Pierre W. Wijermans, Peter A. Jones, Michael Lübbert
Հրապարակվել է 2002Artigo -
12
Persistence of <i><scp>DNMT</scp>3A</i> mutations at long‐term remission in adult patients with <scp>AML</scp> Gro Grunnet Pløen, Line Nederby, Per Guldberg, Maria Hansen, Lene Hyldahl Ebbesen, Uffe Birk Jensen, Peter Hokland, Anni Aggerholm
Հրապարակվել է 2014Artigo -
13
Proteolytic Processing Converts the Repelling Signal Sema3E into an Inducer of Invasive Growth and Lung Metastasis Claus Christensen, Noona Ambartsumian, Giorgio F. Gilestro, Birthe Lykke Thomsen, Paolo M. Comoglio, Luca Tamagnone, Per Guldberg, Eugene Lukanidin
Հրապարակվել է 2005Artigo -
14
Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin-Embedded Cutaneous Melanomas Johanne Lade‐Keller, Kirsten M. Rømer, Per Guldberg, Rikke Riber‐Hansen, Lise Lotte Hansen, Torben Steiniche, Henrik Hager, Lasse S. Kristensen
Հրապարակվել է 2012Artigo -
15
S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance Birgitte Grum-Schwensen, Jörg Klingelhöfer, Mette K. Beck, Charlotte M. Bonefeld, Petra Hamerlik, Per Guldberg, Mariam Grigorian, Eugene Lukanidin, Noona Ambartsumian
Հրապարակվել է 2015Artigo -
16
A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With<i>BRAF</i>Mutations Ann‐Cathrine Larsen, Christina M. Dahmcke, Christina Dahl, Volkert Siersma, Peter Bjerre Toft, Sarah E. Coupland, Jan Ulrik Prause, Per Guldberg, Steffen Heegaard
Հրապարակվել է 2015Revisão -
17
<i><scp>BRAF</scp></i> mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions Ann‐Cathrine Larsen, Christina Dahl, Christina M. Dahmcke, Johanne Lade‐Keller, Volkert Siersma, Peter Bjerre Toft, Sarah E. Coupland, Jan Ulrik Prause, Per Guldberg, Steffen Heegaard
Հրապարակվել է 2016Artigo -
18
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metast... Odd L. Gammelgaard, Mikkel G. Terp, Alexei F. Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten F. Gjerstorff, Henrik J. Ditzel
Հրապարակվել է 2024Artigo -
19
Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer Sofie Traynor, Mie K. Jakobsen, Tina M. Green, Hana Komic, Yaseelan Palarasah, Christina B. Pedersen, Henrik J. Ditzel, Fredrik B. Thorén, Per Guldberg, Morten F. Gjerstorff
Հրապարակվել է 2024Artigo -
20
Congenital Heart Disease in Maternal Phenylketonuria: Report from the Maternal PKU Collaborative Study Harvey L. Levy, Per Guldberg, Flemming Güttler, William Hanley, Reuben Matalon, Bobbye Rouse, Friedrich K. Trefz, Colleen Azen, Elizabeth N. Allred, Felix de la Cruz, Richard Koch
Հրապարակվել է 2001Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Biology
Genetics
Cancer research
Gene
Medicine
Internal medicine
Melanoma
Cancer
DNA methylation
Gene expression
Immunology
Mutation
Oncology
Biochemistry
Methylation
Cell biology
Molecular biology
Allele
Chemistry
DNA
Epigenetics
Amino acid
Antigen
Carcinogenesis
Chronic lymphocytic leukemia
Hyperphenylalaninemia
Leukemia
Lymphoma
PI3K/AKT/mTOR pathway
PTEN